In re HIV Antitrust Litigation
Dec, 2024
In re HIV Antitrust Litigation (N.D. Cal.)
NastLaw is one of two co-lead counsel in this antitrust litigation alleging that manufacturers of certain HIV drugs engaged in a variety of anticompetitive conduct that caused direct purchasers to pay too much for those drugs. Plaintiffs recovered over $257 million on behalf of the direct purchaser classes via two settlements. A court-approved economist is currently processing the claims, and after that is completed, NastLaw will assist with the final allocation and distribution of those funds to eligible class members.